Mark Curran is an accomplished Executive Director at Novartis, where he leads the PSS IHD Field Teams with a focus on enhancing patient access and support in the Immunology marketplace across the Southeast United States. With a strong emphasis on the Buy & Bill and...
Mark Curran is an accomplished Executive Director at Novartis, where he leads the PSS IHD Field Teams with a focus on enhancing patient access and support in the Immunology marketplace across the Southeast United States. With a strong emphasis on the Buy & Bill and Specialty Pharmacy models, Mark is dedicated to addressing the unique needs of customers and patients dealing with complex conditions such as gastrointestinal disorders and breast cancer. His leadership style fosters a high-performance culture, empowering a talented group of reimbursement managers and directors to excel in their roles and deliver exceptional results.
Under Mark's guidance, the team has successfully implemented innovative strategies that enhance sales effectiveness and streamline training processes, ensuring that all team members are equipped with the knowledge and skills necessary to navigate the intricacies of biologics and specialty pharmaceuticals. His commitment to building a cohesive and motivated team has not only driven business results but has also significantly improved patient outcomes by facilitating timely access to critical therapies.
Mark's expertise in anticoagulation and hypertension further enriches his role, allowing him to provide comprehensive support across a range of therapeutic areas. His recognition as a President’s Award Winning Commercial Leader underscores his ability to bridge the gap between commercial objectives and patient-centric care, making him a vital asset to Novartis and the healthcare community. As he continues to champion initiatives that prioritize patient access and education, Mark remains focused on driving innovation and excellence in the ever-evolving landscape of immunology and specialty pharmaceuticals.
